Related Experiment Video
Updated: Oct 16, 2025

10:27
In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
1.7K
A survey of circular RNAs in complex diseases: databases, tools and computational methods
Qiu Xiao1, Jianhua Dai1, Jiawei Luo2
1Hunan Normal University and Hunan Xiangjiang Artificial Intelligence Academy, Changsha, China.
Briefings in Bioinformatics
|October 22, 2021
Summary
Circular RNAs (circRNAs) are key in human diseases, especially cancer. Computational methods efficiently predict circRNA-disease links, aiding diagnosis and therapy development.
Area of Science:
- Molecular Biology
- Genomics
- Bioinformatics
Background:
- Circular RNAs (circRNAs) are novel non-coding RNAs implicated in complex human diseases.
- Many circRNAs are involved in cancer progression, showing potential as diagnostic and therapeutic biomarkers.
- Understanding circRNA-disease relationships is crucial for elucidating disease pathogenesis and circRNA functions.
Purpose of the Study:
- To review databases, tools, and computational methods for predicting circRNA-disease associations.
- To summarize the functions and characteristics of circRNAs in tumorigenesis.
- To discuss future research directions in the field.
Main Methods:
- Review of existing literature, databases, and computational tools.
- Classification of prediction methods into network propagation, path-based, matrix factorization, deep learning, and other machine learning approaches.
- Analysis of circRNAs involved in cancer progression.
Main Results:
- Identification of numerous circRNAs associated with cancer.
- Overview of computational models for predicting circRNA-disease associations.
- Categorization of prediction methods highlights diverse algorithmic strategies.
Conclusions:
- Computational methods offer efficient alternatives to laborious experimental approaches for identifying circRNA-disease links.
- Accurate prediction of circRNA-disease associations can advance understanding of disease mechanisms and improve clinical trial efficiency.
- Further research is needed to address current challenges and refine predictive models.

